Yalei Zhang

机构：First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou Medical University · ORCID：0000-0001-6716-7903

发表论文 25 篇 · 总被引 593 次 · h-index 9

代表论文

Emerging strategies to target RAS signaling in human cancer therapy (2021 · Journal of Hematology & Oncology · 被引 238)
Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis (2019 · Cancer Research · 被引 105)
Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy (2021 · Cancer Cell International · 被引 68)
Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective (2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 47)
Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response (2022 · Molecular Therapy — Oncolytics · 被引 37)
Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study (2024 · Molecular Therapy · 被引 32)